BORTEZOMIB
- Product NDC
- 25021-244
- 11-digit product format
- 250210244
- Labeler code
- 25021
- Product ID
- 25021-244_f083350e-ec7e-415d-85a3-1e48e414dbf2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BORTEZOMIB
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA208392
- Marketing category
- ANDA
- Marketing start
- 2022-05-01
- Marketing end
- 0000-00-00
- Substance
- BORTEZOMIB
- Active strength
- 4 mg/1
- Pharmacologic classes
- Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 25021-244 | BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 1 | Legacy NDC | 20220503_3dd9cc46-9df3-406e-beb4-b6f45459b185.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-244-10 | 25021024410 | 1 VIAL in 1 CARTON (25021-244-10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL | 1 vial | 2022-05-01 | 0000-00-00 | No | No | Current |